• 제목/요약/키워드: treatment strategy

검색결과 1,448건 처리시간 0.023초

Treatment Planning in Smart Medical: A Sustainable Strategy

  • Hao, Fei;Park, Doo-Soon;Woo, Sang Yeon;Min, Se Dong;Park, Sewon
    • Journal of Information Processing Systems
    • /
    • 제12권4호
    • /
    • pp.711-723
    • /
    • 2016
  • With the rapid development of both ubiquitous computing and the mobile internet, big data technology is gradually penetrating into various applications, such as smart traffic, smart city, and smart medical. In particular, smart medical, which is one core part of a smart city, is changing the medical structure. Specifically, it is improving treatment planning for various diseases. Since multiple treatment plans generated from smart medical have their own unique treatment costs, pollution effects, side-effects for patients, and so on, determining a sustainable strategy for treatment planning is becoming very critical in smart medical. From the sustainable point of view, this paper first presents a three-dimensional evaluation model for representing the raw medical data and then proposes a sustainable strategy for treatment planning based on the representation model. Finally, a case study on treatment planning for the group of "computer autism" patients is then presented for demonstrating the feasibility and usability of the proposed strategy.

스트레스 대응전략 -생물학적 접근- (Coping Strategy Against the Stress -It's Biological Approaches-)

  • 정영조
    • 정신신체의학
    • /
    • 제3권1호
    • /
    • pp.72-80
    • /
    • 1995
  • Because the origins of stress are various, complex, and often indirectly-causing, reactions to stress are also various according to it's psychopathologies and mechanisms. For a proper management of stress, first of all accurate evaluation and diagnosis must be done. Then, treatment against the stress also can be considered, if necessary. In case of extreme stress, psychotropic drugs such as short-term anxiolytics or antidepressants can be used according to it's specific target symtoms. But long-term treatment of stress must be directed by increasing the individual's usual coping strategy or decreasing the externally causing stresses. Reactions to stress and drug interactions. which are not the whole of the biologic treatment strategy, are very important As a results, in our discussions, we ought to describe the issues by focusing the interactions between the drug and it's reaction to stress rather than the reaction to stress or drug itself and aimed at helping the proper treatment against the stress.

  • PDF

Change in the treatment strategy for pediatric Crohn's disease

  • Kim, Mi-Jin;Choe, Yon-Ho
    • Clinical and Experimental Pediatrics
    • /
    • 제53권9호
    • /
    • pp.830-833
    • /
    • 2010
  • Crohn's disease is characterized by chronic inflammation involving any portion of the gastrointestinal tract. Treating Crohn's disease is a major challenge for clinicians, as no curative therapy currently exists. Pediatric Crohn's disease is characterized by frequent relapses, a wide extent of disease, a high prevalence of extraintestinal manifestations, and a severe clinical course. The classic therapeutic approach is known as the 'step-up' strategy, and follows a progressive course of treatment intensification as disease severity increases. Although this approach is usually effective for symptom control, many patients become either resistant to or dependent on corticosteroids. The efficacy of infliximab suggests that, rather than a progressive course of treatment, early intense induction may reduce complications associated with conventional treatment and improve quality of life. Intensive early therapy with infliximab is known as the 'top-down' strategy. Such therapy offers the potential for altering the natural history of Crohn's disease, and is changing treatment paradigms. However, the relatively new concept of an early aggressive or 'top-down' treatment approach is not yet widely accepted, especially in pediatric patients. The results of our current study demonstrate that early and intensive treatment of pediatric Crohn's disease patients with infliximab, at initial diagnosis, was more effective for maintaining remission and reducing flares.

Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer

  • Kang, Jeong-Gu;Ko, Jeong-Heon;Kim, Yong-Sam
    • BMB Reports
    • /
    • 제44권12호
    • /
    • pp.765-771
    • /
    • 2011
  • Cancer treatment has been stratified by companion biomarker tests that serve to provide information on the genetic status of cancer patients and to identify patients who can be expected to respond to a given treatment. This stratification guarantees better efficiency and safety during treatment. Cancer patients, however, marginally benefit from the current companion biomarker-aided treatment regimens, presumably because companion biomarker tests are dependent solely on the mutation status of several genes status quo. In the true sense of the term, "personalized medicine", cancer patients are deemed to be identified individually by their molecular signatures, which are not necessarily confined to genetic mutations. Glycosylation is tremendously dynamic and shows alterations in cancer. Evidence is accumulating that aberrant glycosylation contributes to the development and progression of cancer, holding the promise for use of glycosylation status as a companion biomarker in cancer treatment. There are, however, several challenges derived from the lack of a reliable detection system for aberrant glycosylation, and a limited library of aberrant glycosylation. The challenges should be addressed if glycosylation status is to be used as a companion biomarker in cancer treatment and contribute to the fulfillment of personalized medicine.

고혈압 환자들의 관점에서 본 혈압관리에 대한 지식, 태도, 실천: 질적연구 (The Knowledge, Attitude and Practice of Blood Pressure Management from the Patient's Viewpoint: A Qualitative Study)

  • 이석구;전소연
    • Journal of Preventive Medicine and Public Health
    • /
    • 제41권4호
    • /
    • pp.255-264
    • /
    • 2008
  • Objectives: This study adopted a qualitative method to explore the layman's beliefs and experience concerning high blood pressure and its management in order to develop a strategy to increase adherence to proper medical treatment. Methods: Semi-structured interviews that focused on personal experiences with hypertension and its management were conducted with 26 hypertensive patients. The participants were selected according to a BP above 140/90 mmHg (hypertension stage 1), based on the seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure (JNC-VII). The interviews lasted for approximately 30 minutes (range: 20-60 minutes). The resulting questions were formulated into open-ended questions. The interview questionnaire was composed 17 items to examine non-adherence to treatment and 19 items to examine adherence to treatment. Results: Most participants recognized that the direct cause of high blood pressure was unhealthy behavior rather than inheritance. Thus, the hypertensive patient believed they could recover their blood pressure to a normal level through removing the direct cause of hypertension (weight reduction, diet, exercise) instead of taking drugs. The reasons for these statements were that the drugs for controlling hypertension are not natural or they are artificial, and they may have side effects, and drugs are not treatment for the root cause of hypertension. Most of the hypertensive patients chose to manage their behaviors as soon as they knew their blood pressure was high. Therefore, we should not divide the subjects into two groups according to their taking drugs or not, but they should be divided into two groups according to their willingness or not to manage their condition. Conclusions: For developing a strategy for an individual approach to hypertension management, we need to develop a client-centered attitude and strategy. That is, we need to tailor our approach to individual cases to avoid generalizations and stereotyping when developing an adherence increasing strategy.

초기강우 유입 시 하수처리시설 일차 침전지 운전제어 전략 (Control strategy of primary clarifier operation in wastewater treatment plant during rainfall inflow)

  • 유광태;권혁재
    • 한국수자원학회논문집
    • /
    • 제52권11호
    • /
    • pp.947-950
    • /
    • 2019
  • 이 논문의 주요 특징은 초기강우 유입 시 일차 침전지 처리효율을 개선하기 위한 운전제어 전략을 제공하는 것이다. 최근 IoT 기술과 센싱 기술이 발전함에 따라 하수처리시설 운전제어를 위한 기반이 개선되고 있으며, 온라인 측정결과를 활용한 일차침전지 처리효율 개선에 따라 미처리 하수의 하천 유출을 최소화하고, 하수처리시설 운영효율 개선에기여할 수 있다.

뇌졸중 환자의 인지적 전략개발 중심 중재가 수행기술에 미치는 효과 비교 : 무작위 비교연구 (Cognitive Strategy Intervention Affects Performance Skills of Daily Living in Individuals with Stroke: A Randomized Controlled Trial)

  • 안시내
    • 보건의료산업학회지
    • /
    • 제10권3호
    • /
    • pp.75-84
    • /
    • 2016
  • Objectives : The aim of this study was to compare a treatment focusing on the physical function to an intervention focusing on a cognitive strategy in stroke patients which improves their performance skills of daily activities. Methods : This study design was a randomized control trial selecting 43 people with stroke patients. This study consisted of a control group, which received conventional occupational therapy focusing on physical function, and an experimental group which was trained to develop a cognitive strategy by themselves. Both groups each received 10 sessions of the treatment. This study compared the skills for performing daily activities before and after the intervention and analyzed the data with SPSS Ver. 18.0. Results : This study showed a significant improvement in all performance skills in the experimental group (p<.05). There was no statistically significant difference in the performance skills before and after the intervention in the control group (p>.05). Conclusions : It was verified that stroke patients to develop a cognitive strategy by themselves is more effective than to improve the physical function in performance skills for daily activities.

Modulation of Autophagy is a Potential Strategy for Enhancing the Anti-Tumor Effect of Mebendazole in Glioblastoma Cells

  • Jo, Seong Bin;Sung, So Jung;Choi, Hong Seok;Park, Jae-Sung;Hong, Yong-Kil;Joe, Young Ae
    • Biomolecules & Therapeutics
    • /
    • 제30권6호
    • /
    • pp.616-624
    • /
    • 2022
  • Mebendazole (MBZ), a microtubule depolymerizing drug commonly used for the treatment of helminthic infections, has been suggested as a repositioning candidate for the treatment of brain tumors. However, the efficacy of MBZ needs further study to improve the beneficial effect on the survival of those patients. In this study, we explored a novel strategy to improve MBZ efficacy using a drug combination. When glioblastoma cells were treated with MBZ, cell proliferation was dose-dependently inhibited with an IC50 of less than 1 µM. MBZ treatment also inhibited glioblastoma cell migration with an IC50 of less than 3 µM in the Boyden chamber migration assay. MBZ induced G2-M cell cycle arrest in U87 and U373 cells within 24 h. Then, at 72 h of treatment, it mainly caused cell death in U87 cells with an increased sub-G1 fraction, whereas polyploidy was seen in U373 cells. However, MBZ treatment did not affect ERK1/2 activation stimulated by growth factors. The marked induction of autophagy by MBZ was observed, without any increased expression of autophagy-related genes ATG5/7 and Beclin 1. Co-treatment with MBZ and the autophagy inhibitor chloroquine (CQ) markedly enhanced the anti-proliferative effects of MBZ in the cells. Triple combination treatment with temozolomide (TMZ) (another autophagy inducer) further enhanced the anti-proliferative effect of MBZ and CQ. The combination of MBZ and CQ also showed an enhanced effect in TMZ-resistant glioblastoma cells. Therefore, we suggest that the modulation of protective autophagy could be an efficient strategy for enhancing the anti-tumor efficacy of MBZ in glioblastoma cells.

Inhibition of liver fibrosis by sensitization of human hepatic stellate cells by combined treatment with galtanin and TARIL

  • Dong-Oh Moon
    • Journal of Applied Biological Chemistry
    • /
    • 제66권
    • /
    • pp.138-143
    • /
    • 2023
  • Liver fibrosis is caused by metabolic problems such as cholestasis, genetic problems, or viral infections. Inhibiting hepatic stellate cell (HSC) activation or inducing selective apoptosis of activated HSCs is used as a treatment strategy for liver fibrosis. It has been reported that when HSCs are activated, their apoptosis sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is enhanced because the expression of death receptor 5 is elevated. Finding a natural compound that can enhance the apoptotic effect of TRAIL on HSCs is a necessary strategy for liver fibrosis treatment. It was confirmed here that mangosteen-derived gartanin increased the effect of TRAIL-induced apoptosis by increasing the expression of DR5 in a p38-dependent manner in the hepatic stellate cell line LX-2. Combined treatment with gartanin and TRAIL accelerated DNA cleavage through caspase-3 activation and enhanced antifibrotic effects in LX-2 cells.

계획과 검토 단계를 강조한 문제 해결 전략의 효과 (The Instructional Effect of Problem-Solving Strategy Emphasizing Planning and Checking Stages)

  • 전경문;강훈식;노태희
    • 대한화학회지
    • /
    • 제48권2호
    • /
    • pp.182-188
    • /
    • 2004
  • 본 연구에서는 계획과 검토 단계를 강조한 4단계 문제 해결 전략의 교수 효과를 조사하였다. 고등학교 이과 2학년 2개 학급(N=55)을 처치 집단과 통제 집단으로 무선 배치한 후, ''기체''와 ''용액'' 단원에 대하여 8차시 동안 수업하였다. 처치 집단에는 계획과 검토 단계를 강조한 4단계 문제 해결 전략을 사용하였고, 통제 집단에는 전통적인 강의 수업을 실시하였다. 이원 공변량 분석 결과, 화학 문제 해결력 검사에서 처치 집단의 점수가 통제 집단보다 통계적으로 유의미하게 높았으며, 하위 범주 중에서는 ''개념적 지시''과 ''수리적 수행''에서 처치 집단의 점수가 통제 집단보다 유의미하게 높았다. 화학 학습 동기 검사에서는 하위 범주 중 ''만족감''에서 상호작용 효과가 있었는데, 통제 집단 하위 수준 학생들의 점수가 처치 집단 하위 수준 학생들의 점수에 비해 통계적으로 유의미하게 높았다. 메타인지적 기술의 사용에 대한 인식 검사에서는 두 집단 간 유의미한 차이가 없었다. 교육적 함의를 논의하였다.